DEA Refuses to Reconsider the Reclassification of Marijuana
The DEA refuses to reconsider the reclassification of marijuana. According to Criminal justice reporter, Carimah Townes, at ThinkProgress, stated in an article Aug. 12, 2016. Consequently, as a Schedule I drug, cannabis is ranked in with the notorious drugs like heroin and LSD. This also means that the Federal government refuses to accept that cannabis has any medicinal value, despite all of the ongoing evidence and support of Americans.
“It’s really sad that DEA has chosen to continue decades of ignoring the voices of patients who benefit from medical marijuana,” Tom Angell, the chairman of Marijuana Majority, said in a statement. “President Obama always said he would let science — and not ideology — dictate policy, but in this case, his administration is upholding a failed drug war approach instead of looking at real, existing evidence that marijuana has medical value.”
The DEA restricts research
The DEA’s announcement means that the DEA considers cannabis is still as harmful as heroin and more harmful and less beneficial than cocaine! It also bars scientists from any federal funding to research marijuana and inhibits insurance companies from covering any cannabis treatments. A study done by the University of Georgia showed 8 of 9 symptoms, for which the green herb is commonly used; anxiety, depression, glaucoma, nausea, pain, in addition to, psychosis, seizures, sleep disorders and spasticity were successfully treated.
May of 2016, Ohio became the 25th state in this union to recognize and legalize medical cannabis. If your state is not onboard, please contact your state legislators. That is the only way that they know how you, the voters, feel on this important issue. Furthermore, we must hound our federal legislators as well. Write to them, call them and do it often!
If you are unsure of your state’s position, click the link below.
To find out who your state legislators are, click on the link below.
To find out who your federal legislators are, click on the link below.